Hypnosis: a Path to Appeasement
Recruiting · NCT05942885 · Interventional (participants receive a specific treatment) · Lead sponsor: Hospices Civils de Lyon
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...). The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need. Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
Who can take part
Inclusion criteria
- Patients over 18 years old, fluent in French.
- Patients starting hypnotherapy for anxiety disorders.
- Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21
- Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease.
- Diagnosis announcement less than 2 months old
Exclusion criteria
- Persons deprived of their liberty by a judicial or administrative decision
- Adults subject to a legal protection measure
Where it is running
1 location listed.
- Service MB1 - Hôpital Lyon Sud - HCL - Lyon, Pierre-Bénite, France